Developmental Spectrums East Bay Medical Clinic, Inc.

DATA REVEALS THREAT OF SHINGLES EPIDEMIC FROM VACCINE USE - Health Officials Threaten Legal Action Against Researcher Three different analyses of reported cases of shingles and chickenpox were published today in the October 2003 issue of Vaccine and suggest the threat of a shingles epidemic in the US due to mass vaccination with varicella (chickenpox) vaccine - Gary S. Goldman., PhD..

Rashes of Controversy by Gary S. Goldman

INJECTION A fiction medical thriller currently. Perhaps reality in year 2009. INJECTION is about behind-the-scene health issues and their effect on people in a town called Sycamore Springs from 2001 to 2018. A healthcare official with a hero complex convinces the community that a vaccine to protect against a common childhood disease is safe, when in fact, it has not been thoroughly tested. As events unfold, a deleterious effect caused by vaccination surfaces. Health authorities attempt to cover up the finding, but the results are tragic. This fiction account is based on research by Gary S. Goldman, Ph.D., who served nearly eight years as Research/Analyst on a project in a cooperative agreement with the Centers of Disease Control and Prevention (CDC).

Chicken Pox (Varicella) Vaccine Information

more info here

Does this make sense to you???? Chicken Pox vaccine effectiveness decreases after first year
But still yields excellent protection from the virus..

NO URL.

M2 Presswire; 2/18/2004 .

M2 PRESSWIRE-18 February 2004-YALE: Chicken Pox vaccine effectiveness decreases after first year, But still yields excellent protection from the virus(C)1994-2004 M2 COMMUNICATIONS LTD .

RDATE:02172004

"The effectiveness of the varicella vaccine does drop substantially from 99 percent the first year after vaccination to 84 percent two to eight years after vaccination," said first author Marietta Vazquez, M.D., associate research scientist in the Department of Pediatrics at Yale School of Medicine. "But eight years after vaccination, the overall effectiveness is 87 percent, which is still excellent.".

The study, published in the February 18 issue of Journal of the American Medical Association, also suggests that the vaccine might be less effective in the first year after vaccination if it is administered to children less than 15 months of age. Vazquez said this difference in effectiveness disappears after the first year and overall is not significant..

The ongoing study conducted over the past seven years addresses concerns about varicella outbreaks in highly immunized groups that have raised controversy about the effectiveness of the varicella vaccine. The authors assessed whether the effectiveness of varicella vaccine is affected either by time since vaccination or age at the time of vaccination. They studied 339 children ages 13 months or older who were clinically diagnosed with chicken pox after they had been vaccinated with varicella. Two controls were selected for each study participant, matched by age and pediatric practice..

The researchers found the significant decrease in effectiveness one year after vaccination, but most cases of breakthrough disease are mild. .

"The vaccine's effectiveness against moderate or severe disease is excellent throughout the period of the study," said Vazquez. .

Vazquez and her team stress that it will be important to continue monitoring effectiveness of the vaccine since boosts to immunity from exposure to varicella will become increasingly rare as the incidence of varicella diminishes. .

Other authors on the study included senior investigator Eugene D. Shapiro, M.D., Linda M. Niccolai and Catherine E. .

Muchlenbein of Yale; and Philip S. LaRussa, M.D., Anne A. .

Gershon, M.D. and Sharon P. Steinberg of Columbia University. .

Citation: Journal of the American Medical Association, February 18, 2004-Vol. 291, No. 7 .

CONTACT: Karen N. PeartTel: +1 203 432 1326e-mail: This email address is being protected from spam bots, you need Javascript enabled to view it .

((M2 Communications Ltd disclaims all liability for information provided. within M2 PressWIRE. Data prepared by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to This email address is being protected from spam bots, you need Javascript enabled to view it )). .